239 related articles for article (PubMed ID: 26239983)
1. Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.
Reighard KP; Schoenfisch MH
Antimicrob Agents Chemother; 2015 Oct; 59(10):6506-13. PubMed ID: 26239983
[TBL] [Abstract][Full Text] [Related]
2. Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.
Reighard KP; Hill DB; Dixon GA; Worley BV; Schoenfisch MH
Biofouling; 2015; 31(9-10):775-87. PubMed ID: 26610146
[TBL] [Abstract][Full Text] [Related]
3. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
Field TR; White A; Elborn JS; Tunney MM
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
[TBL] [Abstract][Full Text] [Related]
4. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
Barraud N; Hassett DJ; Hwang SH; Rice SA; Kjelleberg S; Webb JS
J Bacteriol; 2006 Nov; 188(21):7344-53. PubMed ID: 17050922
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
8. Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms.
Borriello G; Richards L; Ehrlich GD; Stewart PS
Antimicrob Agents Chemother; 2006 Jan; 50(1):382-4. PubMed ID: 16377718
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents.
Lu Y; Slomberg DL; Schoenfisch MH
Biomaterials; 2014 Feb; 35(5):1716-24. PubMed ID: 24268196
[TBL] [Abstract][Full Text] [Related]
10. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
Kolpen M; Appeldorff CF; Brandt S; Mousavi N; Kragh KN; Aydogan S; Uppal HA; Bjarnsholt T; Ciofu O; Høiby N; Jensen PØ
Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
[TBL] [Abstract][Full Text] [Related]
11. Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens.
Ahonen MJR; Dorrier JM; Schoenfisch MH
ACS Infect Dis; 2019 Aug; 5(8):1327-1335. PubMed ID: 31136714
[TBL] [Abstract][Full Text] [Related]
12. Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.
McCaughey G; Diamond P; Elborn JS; McKevitt M; Tunney MM
PLoS One; 2013; 8(7):e69763. PubMed ID: 23936095
[TBL] [Abstract][Full Text] [Related]
13. Chlorate Specifically Targets Oxidant-Starved, Antibiotic-Tolerant Populations of Pseudomonas aeruginosa Biofilms.
Spero MA; Newman DK
mBio; 2018 Sep; 9(5):. PubMed ID: 30254119
[TBL] [Abstract][Full Text] [Related]
14. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bacterial adhesion and biofilm formation of sulfonated chitosan against Pseudomonas aeruginosa.
Liu Y; Jiang Y; Zhu J; Huang J; Zhang H
Carbohydr Polym; 2019 Feb; 206():412-419. PubMed ID: 30553340
[TBL] [Abstract][Full Text] [Related]
16. Chitosan chemically modified to deliver nitric oxide with high antibacterial activity.
Pelegrino MT; Pieretti JC; Nakazato G; Gonçalves MC; Moreira JC; Seabra AB
Nitric Oxide; 2021 Jan; 106():24-34. PubMed ID: 33098968
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
Habash MB; Goodyear MC; Park AJ; Surette MD; Vis EC; Harris RJ; Khursigara CM
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848007
[TBL] [Abstract][Full Text] [Related]
18. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles.
Slomberg DL; Lu Y; Broadnax AD; Hunter RA; Carpenter AW; Schoenfisch MH
ACS Appl Mater Interfaces; 2013 Oct; 5(19):9322-9. PubMed ID: 24006838
[TBL] [Abstract][Full Text] [Related]
19. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
Eckert R; Brady KM; Greenberg EP; Qi F; Yarbrough DK; He J; McHardy I; Anderson MH; Shi W
Antimicrob Agents Chemother; 2006 Nov; 50(11):3833-8. PubMed ID: 16940063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
